19-859743-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The ENST00000592860.3(CFD):​c.54C>G​(p.Cys18Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000191 in 1,568,920 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000020 ( 0 hom. )

Consequence

CFD
ENST00000592860.3 missense

Scores

1
5
13
Splicing: ADA: 0.001894
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: -1.24

Publications

0 publications found
Variant links:
Genes affected
CFD (HGNC:2771): (complement factor D) This gene encodes a member of the S1, or chymotrypsin, family of serine peptidases. This protease catalyzes the cleavage of factor B, the rate-limiting step of the alternative pathway of complement activation. This protein also functions as an adipokine, a cell signaling protein secreted by adipocytes, which regulates insulin secretion in mice. Mutations in this gene underlie complement factor D deficiency, which is associated with recurrent bacterial meningitis infections in human patients. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate the mature protease. [provided by RefSeq, Nov 2015]
CFD Gene-Disease associations (from GenCC):
  • recurrent Neisseria infections due to factor D deficiency
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFDNM_001928.4 linkc.54C>G p.Cys18Trp missense_variant, splice_region_variant Exon 1 of 5 ENST00000327726.11 NP_001919.2 P00746
CFDNM_001317335.2 linkc.54C>G p.Cys18Trp missense_variant Exon 1 of 5 NP_001304264.1 P00746K7ERG9A6XNE2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFDENST00000327726.11 linkc.54C>G p.Cys18Trp missense_variant, splice_region_variant Exon 1 of 5 1 NM_001928.4 ENSP00000332139.4 P00746

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152168
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000562
AC:
1
AN:
177996
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000138
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000198
AC:
28
AN:
1416752
Hom.:
0
Cov.:
31
AF XY:
0.0000200
AC XY:
14
AN XY:
700786
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32650
American (AMR)
AF:
0.00
AC:
0
AN:
38060
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25354
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37674
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80742
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49358
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5560
European-Non Finnish (NFE)
AF:
0.0000248
AC:
27
AN:
1088748
Other (OTH)
AF:
0.0000171
AC:
1
AN:
58606
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152168
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41442
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67998
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 22, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.54C>G (p.C18W) alteration is located in exon 1 (coding exon 1) of the CFD gene. This alteration results from a C to G substitution at nucleotide position 54, causing the cysteine (C) at amino acid position 18 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Jul 20, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). This variant has not been reported in the literature in individuals affected with CFD-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.004%). This sequence change replaces cysteine, which is neutral and slightly polar, with tryptophan, which is neutral and slightly polar, at codon 18 of the CFD protein (p.Cys18Trp). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Uncertain
0.048
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
14
DANN
Benign
0.97
DEOGEN2
Uncertain
0.51
D;.
Eigen
Benign
-0.76
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.028
N
LIST_S2
Benign
0.41
T;T
M_CAP
Pathogenic
0.36
D
MetaRNN
Uncertain
0.55
D;D
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
2.0
M;.
PhyloP100
-1.2
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-1.9
N;.
REVEL
Uncertain
0.32
Sift
Benign
0.13
T;.
Sift4G
Benign
0.16
T;D
Polyphen
1.0
D;.
Vest4
0.42
MutPred
0.63
Gain of MoRF binding (P = 0.0106);Gain of MoRF binding (P = 0.0106);
MVP
0.79
MPC
0.98
ClinPred
0.33
T
GERP RS
-2.5
PromoterAI
-0.13
Neutral
Varity_R
0.11
gMVP
0.57
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0019
dbscSNV1_RF
Benign
0.076
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1363632175; hg19: chr19-859743; API